What is he best known for?
The fields of study he is best known for:
- Polymer
- Biochemistry
- Cancer
Jianxun Ding mainly investigates Drug delivery, Micelle, Ethylene glycol, Doxorubicin and Polymer chemistry.
His Drug delivery research focuses on Nanocarriers in particular.
The Micelle study combines topics in areas such as Hydrophobic effect, Biophysics, Targeted drug delivery and Drug carrier.
His biological study spans a wide range of topics, including Intracellular and Controlled release.
His Ethylene glycol research includes themes of Biocompatibility, Chromatography and Self-healing hydrogels.
His studies deal with areas such as In vitro, Biochemistry, Nanogel, Pharmacology and Nanomedicine as well as Doxorubicin.
His most cited work include:
- Sequentially Responsive Shell-Stacked Nanoparticles for Deep Penetration into Solid Tumors (192 citations)
- Mesenchymal Stem Cells for Regenerative Medicine. (176 citations)
- Electrospun polymer biomaterials (176 citations)
What are the main themes of his work throughout his whole career to date?
Jianxun Ding focuses on Drug delivery, Micelle, Doxorubicin, Ethylene glycol and Cancer research.
His Drug delivery study is related to the wider topic of Nanotechnology.
In his work, Nanoparticle is strongly intertwined with Polymer, which is a subfield of Nanotechnology.
He interconnects Biophysics, Amphiphile, Stereochemistry and Drug carrier in the investigation of issues within Micelle.
He has included themes like In vitro, Pharmacology, Controlled release, Nanogel and Intracellular in his Doxorubicin study.
His Ethylene glycol research also works with subjects such as
- Polymerization most often made with reference to Polymer chemistry,
- Self-healing hydrogels that connect with fields like Tissue engineering.
He most often published in these fields:
- Drug delivery (25.68%)
- Micelle (19.52%)
- Doxorubicin (17.81%)
What were the highlights of his more recent work (between 2018-2021)?
- Cancer research (16.10%)
- Biomedical engineering (15.07%)
- Drug delivery (25.68%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Cancer research, Biomedical engineering, Drug delivery, Nanotechnology and Polymer.
The study incorporates disciplines such as Chemotherapy, Doxorubicin, Immune system, Immunogenic cell death and Metastasis in addition to Cancer research.
His work carried out in the field of Doxorubicin brings together such families of science as Pharmacokinetics, Micelle and Distribution.
Jianxun Ding studied Biomedical engineering and Regeneration that intersect with Cartilage, Tissue engineering and Peripheral nerve.
His Drug delivery research integrates issues from In vitro, Cisplatin, Ethylene glycol and Pharmacology, Drug.
His study looks at the relationship between Nanotechnology and fields such as Cancer therapy, as well as how they intersect with chemical problems.
Between 2018 and 2021, his most popular works were:
- Mesenchymal Stem Cells for Regenerative Medicine. (176 citations)
- Electrospun polymer biomaterials (176 citations)
- Engineered nanomedicines with enhanced tumor penetration (99 citations)
In his most recent research, the most cited papers focused on:
- Polymer
- Organic chemistry
- Cancer
His main research concerns Cancer research, Nanotechnology, Drug delivery, Biomedical engineering and Tissue engineering.
His research integrates issues of Tumor penetration, Blood supply, Anticancer immunity and Nanomedicine in his study of Cancer research.
His Nanotechnology research is multidisciplinary, relying on both Cancer therapy and Electrospinning, Polymer.
Jianxun Ding performs multidisciplinary study in Drug delivery and Floating platform in his work.
His Biomedical engineering study integrates concerns from other disciplines, such as Biocompatibility and Cartilage.
His research in Tissue engineering intersects with topics in Functional recovery, Regenerative medicine, Transplantation and Regeneration.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
